GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (STU:7QD) » Definitions » Change In Receivables

Clover Health Investments (STU:7QD) Change In Receivables : €525 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Change In Receivables?

Clover Health Investments's change in receivables for the quarter that ended in Mar. 2024 was €-68 Mil. It means Clover Health Investments's Accounts Receivable increased by €68 Mil from Dec. 2023 to Mar. 2024 .

Clover Health Investments's change in receivables for the fiscal year that ended in Dec. 2023 was €49 Mil. It means Clover Health Investments's Accounts Receivable declined by €49 Mil from Dec. 2022 to Dec. 2023 .

Clover Health Investments's Accounts Receivable for the quarter that ended in Mar. 2024 was €0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Clover Health Investments's Days Sales Outstanding for the three months ended in Mar. 2024 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Clover Health Investments's liquidation value for the three months ended in Mar. 2024 was €-33 Mil.


Clover Health Investments Change In Receivables Historical Data

The historical data trend for Clover Health Investments's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Change In Receivables Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
54.68 -32.81 -21.75 -54.57 49.26

Clover Health Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -550.55 577.22 -14.14 30.15 -68.17

Clover Health Investments Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €525 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover Health Investments  (STU:7QD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Clover Health Investments's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/319.168*91
=0.00

2. In Ben Graham's calculation of liquidation value, Clover Health Investments's accounts receivable are only considered to be worth 75% of book value:

Clover Health Investments's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=315.646-348.952+0.75 * 0+0.5 * 0
=-33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover Health Investments Change In Receivables Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover Health Investments (STU:7QD) Business Description

Traded in Other Exchanges
Address
3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.

Clover Health Investments (STU:7QD) Headlines

No Headlines